DGAP-Ad-hoc: NORMA Group SE / Key word(s): Personnel/Personnel
Maintal, August 26, 2022 – Dr. Michael Schneider, Chairman of the Management Board of NORMA Group SE (ISIN DE 000A1H8BV3 / WKN A1H8BV, "NORMA Group"), and the Supervisory Board of NORMA Group mutually agreed today not to extend the contract of Dr. Schneider which ends on June 30, 2023. Since 2015 Dr. Schneider served as Chief Financial Officer and in 2019 was appointed as CEO of NORMA Group.
The Supervisory Board will commence a structured search for a successor of Dr. Schneider in his role as CEO. Dr. Schneider will ensure jointly with the two other members of the Management Board an orderly transmission and leave the Management Board of NORMA Group SE on December 31, 2022. Contact: Andreas Trösch Vice President Investor Relations, Communications and Corporate Responsibility E-mail: Andreas.Troesch@normagroup.com Phone: +49 (0)6181 – 6102 741 End of Ad hoc disclosure
26-Aug-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | NORMA Group SE |
Edisonstr. 4 | |
63477 Maintal | |
Germany | |
Phone: | +49 6181 6102 741 |
Fax: | +49 6181 6102 7641 |
E-mail: | ir@normagroup.com |
Internet: | www.normagroup.com |
ISIN: | DE000A1H8BV3 |
WKN: | A1H8BV |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1429105 |
End of Announcement | DGAP News Service |
|
1429105 26-Aug-2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.